INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

BDR Pharma buys majority stake in Acme’s oral solids formulations business

1 source1 article First seen Updated India Truth score 34

Save Like Comments Compare coverage
Image from Livemint

Summary

Existing investors, including private equity firm PAG, are selling their stakes in Acme's oral solids formulations business in a transaction that is expected to value the business at about $250 million.

Description from Livemint.

Who is covering this

  1. Livemint Center IN
    BDR Pharma buys majority stake in Acme’s oral solids formulations business

    Existing investors, including private equity firm PAG, are selling their stakes in Acme's oral solids formulations business in a transaction that is expected to value the business at about $250 million.

Comments

Comments need JavaScript.